Paul Hollenbach

1 Patent

• US115901172023

  Treatment of a Hematologic Malignancy with 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide

  Celgene Corporation

  0 cites